Robert Malenka
Fortune : 10 M $ au 31/05/2026
Fortune : 10 M $ au 31/05/2026
Robert Malenka is the founder of MapLight Therapeutics, Inc., founded in 2018, where the title held is Director.
Current jobs include Deputy Director at Wu Tsai Neurosciences Institute and Member at the National Academy of Medicine (United States).
Former job includes Professor at the University of California from 1996 to 1999.
Education includes a doctorate from Stanford University School of Medicine, conferred in 1983.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/04/2026 | 348 138 ( 0,82% ) | 10 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Corporate Officer/Principal | - |
| Sociétés | Poste | Fin |
|---|---|---|
| MAPLIGHT THERAPEUTICS, INC. | Fondateur | 23/06/2026 |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1999 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Commercial Services |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MapLight Therapeutics, Inc.
MapLight Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for debilitating central nervous system disorders | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national